BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang CJ, Byun MJ, Kim S, Park W, Park HH, Kim T, Lee JS, Park CG. Biomaterials as therapeutic drug carriers for inflammatory bowel disease treatment. Journal of Controlled Release 2022. [DOI: 10.1016/j.jconrel.2022.02.028] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Xiao M, Wu S, Cheng Y, Ma J, Luo X, Chang L, Zhang C, Chen J, Zou L, You Y, Zhang J. Colon-specific delivery of isoliquiritigenin by oral edible zein/caseate nanocomplex for ulcerative colitis treatment. Front Chem 2022;10:981055. [DOI: 10.3389/fchem.2022.981055] [Reference Citation Analysis]
2 Pedro AC, Paniz OG, Fernandes IDAA, Bortolini DG, Rubio FTV, Haminiuk CWI, Maciel GM, Magalhães WLE. The Importance of Antioxidant Biomaterials in Human Health and Technological Innovation: A Review. Antioxidants 2022;11:1644. [DOI: 10.3390/antiox11091644] [Reference Citation Analysis]
3 Li DF, Yang MF, Xu HM, Zhu MZ, Zhang Y, Tian CM, Nie YQ, Wang JY, Liang YJ, Yao J, Wang LS. Nanoparticles for oral delivery: targeted therapy for inflammatory bowel disease. J Mater Chem B 2022. [PMID: 35876136 DOI: 10.1039/d2tb01190e] [Reference Citation Analysis]